Sample Size Reassessment in Adaptive Clinical Trials Using a Bias Corrected Estimate

Point estimation in group sequential and adaptive trials is an important issue in analysing a clinical trial. Most literature in this area is only concerned with estimation after completion of a trial. Since adaptive designs allow reassessment of sample size during the trial, reliable point estimation of the true effect when continuing the trial is additionally needed. We present a bias adjusted estimator which allows a more exact sample size determination based on the conditional power principle than the naive sample mean does.